§ CERTIFICATE OF ANALYSIS · THIRD-PARTY HPLC · NOV-2025● VERIFIED SUBMISSION · PUBLIC RECORD

Home › Lab Tests › NextGen Peptides, Tirzepatide

◆ Batch ID · TR28✓ Verified · Pass

Tirzepatide × NextGen Peptides - Lab Test, November 2025

Tested Monday, November 03, 2025 · submitted by @Frank 👑 Legend

HPLC Purity

99.85%

✓ Excellent

PeptideTirzepatide

Brandnexxgenpeptides.com

LabBioRegen

↓ Download COA 🔗 Share

Test results

7 data points

Purity

99.85%

Endotoxins

Not tested

Stated qty

20 mg

Tested qty

23.4 mg

Qty match

117% of labeled · +17%

Batch ID

TR28

Container

White Lyophilized Powder

Tested by

BioRegenView profile →

◆ Quantity verification

20 mg→23.4 mg+17%

About this test

This independent LC-MS lab test confirms Tirzepatide 20mg from NextGen Peptides at 99.85% purity. The analysis was conducted by BioRegen on November 3, 2025, with a batch ID of TR28.

Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 99.85% indicates minimal contamination and high-grade synthesis. The product was delivered as a white lyophilized powder with a molecular weight of 4813 g/mol.

Identity confirmation by Ultra High Performance Liquid Chromatography with Mass Spectrometry (LC-MS) validates the compound structure and composition. The full certificate of analysis is available for download on this page.